Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. [electronic resource]
Producer: 20060307Description: 198-202 p. digitalISSN:- 0003-987X
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Arthritis, Psoriatic -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Biopsy
- Diagnosis, Differential
- Drug Eruptions -- etiology
- Etanercept
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Lenalidomide
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Fusion Proteins -- adverse effects
- Skin -- pathology
- Thalidomide -- adverse effects
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.